Protection of gonadal function from cytotoxic chemotherapy and irradiation.
I D
ID
Morris
S M
SM
Shalet
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002945:Cisplatin / Q000494:pharmacology; D003520:Cyclophosphamide / Q000494:pharmacology; D004285:Dogs; D004317:Doxorubicin / Q000494:pharmacology; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D010053:Ovary / Q000187:drug effects*; D010906:Pituitary Hormone-Releasing Hormones / Q000037:antagonists & inhibitors; D011344:Procarbazine / Q000494:pharmacology; D011832:Radiation Injuries / Q000517:prevention & control*; D011878:Radiotherapy / Q000009:adverse effects*; D051381:Rats; D013737:Testis / Q000187:drug effects*
D000970:Antineoplastic Agents; D010906:Pituitary Hormone-Releasing Hormones; D011344:Procarbazine; D004317:Doxorubicin; D003520:Cyclophosphamide; D002945:Cisplatin